Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients With Schizophrenia.

Trial Profile

Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients With Schizophrenia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2015

At a glance

  • Drugs Aripiprazole (Primary) ; Olanzapine (Primary) ; Quetiapine (Primary) ; Flupentixol; Haloperidol
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms NeSSy
  • Most Recent Events

    • 19 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 26 Aug 2011 New source identified and integrated (German Clinical Trials Register).
    • 27 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top